Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...

As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

If you’re feeling under the weather, chances are pretty high that you have one of four popular viruses going around: influenza A (the flu), COVID-19, norovirus (the stomach flu) and respiratory ...

The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

RSV leads to 58,000–80,000 hospitalizations among children younger than 5 years ... antibody given to infants after birth. Is there a treatment for RSV? What to do if you think you have RSV ...

UPMC saw an increase in RSV cases in its health system, including in Lancaster County, a spokesperson said Jan. 7, especially ...

Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that primarily affects infants and older adults, ...